[1] HUNTER DJ, BIERMA-ZEINSTRA S. Osteoarthritis. Lancet. 2019;393(10182):1745-1759.
[2] MUSUMECI G, AIELLO FC, SZYCHLINSKA MA, et al. Osteoarthritis in the XXIst century: risk factors and behaviours that influence disease onset and progression. Int J Mol Sci. 2015;16(3):6093-6112.
[3] MOBASHERI A, BATT M. An update on the pathophysiology of osteoarthritis. Ann Phys Rehabil Med. 2016;59(5-6):333-339.
[4] ABRAMOFF B, CALDERA FE. Osteoarthritis: pathology, diagnosis, and treatment options. Med Clin. 2020;104(2):293-311.
[5] GOZZELINO R, AROSIO P. Iron homeostasis in health and disease. Int J Mol Sci. 2016;17(1):130.
[6] LI C, OUYANG N, WANG X, et al. Association between the ABO blood group and primary knee osteoarthritis: a case-control study. J Orthop Translat. 2020;21:129-135.
[7] LOESER RF, COLLINS JA, DIEKMAN BO. Ageing and the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2016;12(7):412-420.
[8] HOSSEINZADEH A, KAMRAVA SK, JOGHATAEI MT, et al. Apoptosis signaling pathways in osteoarthritis and possible protective role of melatonin. J Pineal Res. 2016;61(4):411-425.
[9] YAO X, SUN K, YU S, et al. Chondrocyte ferroptosis contribute to the progression of osteoarthritis. J Orthop Translat. 2021;27:33-43.
[10] ZHAO LR, XING RL, WANG PM, et al. NLRP1 and NLRP3 inflammasomes mediate LPS/ATP‑induced pyroptosis in knee osteoarthritis. Mol Med Rep. 2018;17(4):5463-5469.
[11] COOKSON BT, BRENNAN MA. Pro-inflammatory programmed cell death. Trends Microbiol. 2001;9(3):113-114.
[12] GAO YL, ZHAI JH, CHAI YF. Recent Advances in the Molecular Mechanisms Underlying Pyroptosis in Sepsis. Mediators Inflamm. 2018;2018:5823823.
[13] HERSH D, MONACK DM, SMITH MR, et al. The Salmonella invasin SipB induces macrophage apoptosis by binding to caspase-1. Proc Natl Acad Sci U S A. 1999;96(5):2396-2401.
[14] FERNANDES-ALNEMRI T, WU J, YU JW, et al. The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell Death Differ. 2007;14(9):1590-1604.
[15] ZHAOLIN Z, GUOHUA L, SHIYUAN W, et al. Role of pyroptosis in cardiovascular disease. Cell Prolif. 2019;52(2):e12563.
[16] SCHEIBE K, KERSTEN C, SCHMIED A, et al. Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice With Chronic Intestinal Inflammation. Gastroenterology. 2019;156(4):1082-1097.e1011.
[17] HANSON B. Necroptosis: A new way of dying? Cancer Biol Ther. 2016;17(9): 899-910.
[18] CORR EM, CUNNINGHAM CC, HELBERT L, et al. Osteoarthritis-associated basic calcium phosphate crystals activate membrane proximal kinases in human innate immune cells. Arthritis Res Ther. 2017;19(1):23.
[19] VANDANMAGSAR B, YOUM YH, RAVUSSIN A, et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med. 2011;17(2):179-188.
[20] 智佳佳.软骨细胞焦亡中ROS/NLRP3通路促进炎症因子分泌的实验研究[D].太原:山西医科大学,2021.
[21] ZHAO Y, SHI J, SHAO F. Inflammatory Caspases: Activation and Cleavage of Gasdermin-D In Vitro and During Pyroptosis. Methods Mol Biol. 2018; 1714:131-148.
[22] 智佳佳,杜朝政,王宇泽.骨关节炎形成过程中细胞焦亡的作用与机制[J].中国组织工程研究,2021,25(32):5204-5209
[23] LI C, LI L, LAN T. Co-treatment with disulfiram and glycyrrhizic acid suppresses the inflammatory response of chondrocytes. J Orthop Surg Res. 2021;16(1):132.
[24] WANG S, MOBASHERI A, ZHANG Y, et al. Exogenous stromal cell-derived factor-1 (SDF-1) suppresses the NLRP3 inflammasome and inhibits pyroptosis in synoviocytes from osteoarthritic joints via activation of the AMPK signaling pathway. Inflammopharmacology. 2021;29(3):695-704.
[25] HASEEB A, HAQQI TM. Immunopathogenesis of osteoarthritis. Clin Immunol. M2013;146(3):185-196.
[26] LI Z, HUANG Z, BAI L. The P2X7 Receptor in Osteoarthritis. Front Cell Dev Biol. 2021;9:628330.
[27] LIU G, LIU Q, YAN B, et al. USP7 Inhibition Alleviates H(2)O(2)-Induced Injury in Chondrocytes via Inhibiting NOX4/NLRP3 Pathway. Front Pharmacol. 2020;11:617270.
[28] YU H, YAO S, ZHOU C, et al. Morroniside attenuates apoptosis and pyroptosis of chondrocytes and ameliorates osteoarthritic development by inhibiting NF-κB signaling. J Ethnopharmacol. 2021;266:113447.
[29] YAN Z, QI W, ZHAN J, et al. Activating Nrf2 signalling alleviates osteoarthritis development by inhibiting inflammasome activation. J Cell Mol Med. 2020; 24(22):13046-13057.
[30] HU J, ZHOU J, WU J, et al. Loganin ameliorates cartilage degeneration and osteoarthritis development in an osteoarthritis mouse model through inhibition of NF-κB activity and pyroptosis in chondrocytes. J Ethnopharmacol. 2020;247:112261.
[31] ZU Y, MU Y, LI Q, et al. Icariin alleviates osteoarthritis by inhibiting NLRP3-mediated pyroptosis. J Orthop Surg Res. 2019;14(1):307.
[32] VAN HERREWEGHE F, FESTJENS N, DECLERCQ W, et al. Tumor necrosis factor-mediated cell death: to break or to burst, that’s the question. Cell Mol Life Sci. 2010;67(10):1567-1579.
[33] ZHANG Y, CHEN X, GUEYDAN C, et al. Plasma membrane changes during programmed cell deaths. Cell Res. 2018;28(1):9-21.
[34] SUN L, WANG H, WANG Z, et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell. 2012;148(1-2): 213-227.
[35] HITOMI J, CHRISTOFFERSON DE, NG A, et al. Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell. 2008;135(7):1311-1323.
[36] LINKERMANN A, GREEN DR. Necroptosis. N Engl J Med. 2014;370(5):455-465.
[37] SMITH CC, DAVIDSON SM, LIM SY, et al. Necrostatin: a potentially novel cardioprotective agent? Cardiovasc Drugs Ther. 2007;21(4):227-233.
[38] LIN J, LI H, YANG M, et al. A role of RIP3-mediated macrophage necrosis in atherosclerosis development. Cell Rep. 2013;3(1):200-210.
[39] LINKERMANN A, BRÄSEN JH, HIMMERKUS N, et al. Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury. Kidney Int. 2012;81(8):751-761.
[40] WU J, HUANG Z, REN J, et al. Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis. Cell Res. 2013;23(8):994-1006.
[41] WELZ PS, WULLAERT A, VLANTIS K, et al. FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature. 2011; 477(7364):330-334.
[42] LIANG S, LV ZT, ZHANG JM, et al. Necrostatin-1 Attenuates Trauma-Induced Mouse Osteoarthritis and IL-1β Induced Apoptosis via HMGB1/TLR4/SDF-1 in Primary Mouse Chondrocytes. Front Pharmacol. 2018;9:1378.
[43] CHENG J, DUAN X, FU X, et al. RIP1 Perturbation Induces Chondrocyte Necroptosis and Promotes Osteoarthritis Pathogenesis via Targeting BMP7. Front Cell Dev Biol. 2021;9:638382.
[44] CHEN X, CHEN R, XU Y, et al. PLCγ1 inhibition combined with inhibition of apoptosis and necroptosis increases cartilage matrix synthesis in IL-1β-treated rat chondrocytes. FEBS Open Bio. 2021;11(2):435-445.
[45] RIEGGER J, BRENNER RE. Evidence of necroptosis in osteoarthritic disease: investigation of blunt mechanical impact as possible trigger in regulated necrosis. Cell Death Dis. 2019;10(10):683.
[46] ZHANG C, LIN S, LI T, et al. Mechanical force-mediated pathological cartilage thinning is regulated by necroptosis and apoptosis. Osteoarthritis Cartilage. 2017;25(8):1324-1334.
[47] JEON J, NOH HJ, LEE H, et al. TRIM24-RIP3 axis perturbation accelerates osteoarthritis pathogenesis. Ann Rheum Dis. 2020;79(12):1635-1643.
[48] GONG Y, QIU J, YE J, et al. AZ-628 delays osteoarthritis progression via inhibiting the TNF-α-induced chondrocyte necroptosis and regulating osteoclast formation. Int Immunopharmacol. 2022;111:109085.
[49] STOCKWELL BR, FRIEDMANN ANGELI JP, BAYIR H, et al. Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease. Cell. 2017; 171(2):273-285.
[50] YU Y, JIANG L, WANG H, et al. Hepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis. Blood. 2020;136(6):726-739.
[51] FANG X, CAI Z, WANG H, et al. Loss of Cardiac Ferritin H Facilitates Cardiomyopathy via Slc7a11-Mediated Ferroptosis. Circ Res. 2020;127(4):486-501.
[52] STOCKWELL BR, JIANG X, GU W. Emerging Mechanisms and Disease Relevance of Ferroptosis. Trends Cell Biol. 2020;30(6):478-490.
[53] SHA W, HU F, XI Y, et al. Mechanism of Ferroptosis and Its Role in Type 2 Diabetes Mellitus. J Diabetes Res. 2021;2021:9999612.
[54] SUN Y, CHEN P, ZHAI B, et al. The emerging role of ferroptosis in inflammation. Biomed Pharmacother. 2020;127:110108.
[55] JING X, LIN J, DU T, et al. Iron Overload Is Associated With Accelerated Progression of Osteoarthritis: The Role of DMT1 Mediated Iron Homeostasis. Front Cell Dev Biol. 2020;8:594509.
[56] YAO X, SUN K, YU S, et al. Chondrocyte ferroptosis contribute to the progression of osteoarthritis. J Orthop Translat. 2020;27:33-43.
[57] ZHOU X, ZHENG Y, SUN W, et al. D-mannose alleviates osteoarthritis progression by inhibiting chondrocyte ferroptosis in a HIF-2α-dependent manner. Cell Prolif. 2021;54(11):e13134.
[58] WANG FS, KUO CW, KO JY, et al. Irisin Mitigates Oxidative Stress, Chondrocyte Dysfunction and Osteoarthritis Development through Regulating Mitochondrial Integrity and Autophagy. Antioxidants (Basel). 2020;9(9):810.
[59] JING X, DU T, LI T, et al. The detrimental effect of iron on OA chondrocytes: Importance of pro-inflammatory cytokines induced iron influx and oxidative stress. J Cell Mol Med. 2021;25(12):5671-5680.
[60] JING X, WANG Q, DU T, et al. Calcium chelator BAPTA‑AM protects against iron overload‑induced chondrocyte mitochondrial dysfunction and cartilage degeneration. Int J Mol Med. 2021;48(4):196.
[61] LIU XJ, LV YF, CUI WZ, et al. Icariin inhibits hypoxia/reoxygenation-induced ferroptosis of cardiomyocytes via regulation of the Nrf2/HO-1 signaling pathway. FEBS Open Bio. 2021;11(11):2966-2976. |